Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Hemidystonia-hemiatrophy (HD-HA) is a rare dystonia, usually caused by a static cerebral injury occurring at birth or during infancy, that is characterized by a combination of hemidystonia (HD), involving one half of the body, and hemiatrophy (HA) on the same side as the HD.
Biomarker and diagnostic research for hemidystonia-hemiatrophy syndrome has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for hemidystonia-hemiatrophy syndrome.
96 publications have been identified in PubMed for hemidystonia-hemiatrophy syndrome. Research spans Review / Meta-Analysis (58%), Basic Science / Preclinical (15%), and Case Report / Case Series (10%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 56 | 58% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 3:09 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Laboratory research
14 |
15% |
Patient case studies | 10 | 10% |
Testing and diagnosis research | 6 | 6% |
Disease patterns and progression | 5 | 5% |
New treatment approaches | 3 | 3% |
Clinical study results | 2 | 2% |
Anderson EN (2026). [PMID: 41468891](https://pubmed.ncbi.nlm.nih.gov/41468891/). *American journal of human genetics*. [Basic Science / Preclinical]
Sebode M (2026). [PMID: 41432137](https://pubmed.ncbi.nlm.nih.gov/41432137/). *Current opinion in gastroenterology*. [Review / Meta-Analysis]
Amado C (2026). [PMID: 40975490](https://pubmed.ncbi.nlm.nih.gov/40975490/). *Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology*. [Basic Science / Preclinical]
Karuntu JS (2025). [PMID: 39733931](https://pubmed.ncbi.nlm.nih.gov/39733931/). *Progress in retinal and eye research*. [Review / Meta-Analysis]
Pena C (2025). [PMID: 40146047](https://pubmed.ncbi.nlm.nih.gov/40146047/). *Minerva medica*. [Review / Meta-Analysis]
Sullivan MM (2025). [PMID: 40153327](https://pubmed.ncbi.nlm.nih.gov/40153327/). *Clinical and experimental rheumatology*. [Review / Meta-Analysis]
Calafat M (2025). [PMID: 40081635](https://pubmed.ncbi.nlm.nih.gov/40081635/). *Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association*. [Review / Meta-Analysis]
Short E (2025). [PMID: 39304617](https://pubmed.ncbi.nlm.nih.gov/39304617/). *GeroScience*. [Review / Meta-Analysis]
Jachiet V (2025). [PMID: 40476413](https://pubmed.ncbi.nlm.nih.gov/40476413/). *La Revue du praticien*. [Review / Meta-Analysis]
Sánchez-Camacho A (2025). [PMID: 40406130](https://pubmed.ncbi.nlm.nih.gov/40406130/). *Frontiers in immunology*. [Case Report / Case Series]